Default: Cancer Gene Therapy

ISSN: 0929-1903

Journal Home

Journal Guideline

Cancer Gene Therapy Q1 Unclaimed

Nature Publishing Group United Kingdom
Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Cancer Gene Therapy is a journal indexed in SJR in Molecular Biology and Molecular Medicine with an H index of 99. It has a price of 3490 €. It has an SJR impact factor of 1,457 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,457.

Cancer Gene Therapy focuses its scope in these topics and keywords: tumor, cancer, rna, cells, virus, gene, induces, targeting, necrosis, breast, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Price

3490 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

Cancer Gene Therapy

1,457

SJR Impact factor

99

H Index

165

Total Docs (Last Year)

367

Total Docs (3 years)

9395

Total Refs

1780

Total Cites (3 years)

354

Citable Docs (3 years)

4.96

Cites/Doc (2 years)

56.94

Ref/Doc

Comments

No comments ... Be the first to comment!

Aims and Scope


tumor, cancer, rna, cells, virus, gene, induces, targeting, necrosis, breast, indiasystemic, infiltrating, leukemiaexosomes, liver, meg, metastases, immunoinhibitory, immunecompetent, growth, approach, bifunctional, characterization, enhanced, experimental, factor?, focusing, gastric, glioma, gmcsf,



Best articles by citations

Purging of human breast cancer cells from stem cell products with an adenovirus containing p53

View more

Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity

View more

The cellular oncogene EWS/activating transcription factor 1 is unable to activate adenovirus-borne promoters: Implications for cytotoxic prodrug therapy of malignant melanoma of soft parts

View more

Development of a murine orthotopic model of leukemia: Evaluation of TP53 gene therapy efficacy

View more

Inhibition of glioma cells in vitro and in vivo using a recombinant adenoviral vector containing an astrocyte-specific promoter

View more

Expression of the prodrug-activating enzyme DT-diaphorase via Ad5 delivery to human colon carcinoma cells in vitro

View more

Induction of Influenza Matrix Protein 1 and MelanA-specific T lymphocytes in vitro using mRNA-electroporated dendritic cells

View more

Cloning and analysis of human UroplakinII promoter and its application for gene therapy in bladder cancer

View more

Interleukin-2 gene-transduced human leukemic cells induce major histocompatibility complex-restricted and -unrestricted anti-leukemic effectors in mixed lymphocyte-tumor cultures

View more

A nonviral carrier for targeted gene delivery to tumor cells

View more

Lipofection of early passages of cell cultures derived from murine adenocarcinomas: In vitro and ex vivo testing of the thymidine kinase/ganciclovir system

View more

Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells

View more
SHOW MORE ARTICLES

Transduction of murine colon carcinoma cells with interleukin-15 gene induces antitumor effects in immunocompetent and immunocompromised hosts

View more

Enhanced antitumor effect of EGF R-targeted p21WAF-1 and GM-CSF gene transfer in the established murine hepatoma by peritumoral injection

View more

Cytosine deaminase suicide gene therapy for peritoneal carcinomatosis

View more

Enhanced antitumoral effect of adenovirus-mediated cytosine deaminase gene therapy by induction of antigen-presenting cells through stem cell factor/granulocyte-macrophage colony-stimulating factor gene transfer

View more

Induction of long-lasting cytokine effect by injection of IL-12 encoding plasmid DNA

View more

Long-term effects of plasmid-mediated growth hormone releasing hormone in dogs

View more

Bone marrow-derived cells as carriers of recombinant immunomodulatory cytokine genes to lymphoid organs

View more

Adenoviral delivery of A-FOS, an AP-1 dominant negative, selectively inhibits drug resistance in two human cancer cell lines

View more

Construction and characterization of DNA vaccines encoding the single-chain variable fragment of the anti-idiotype antibody 1A7 mimicking the tumor-associated antigen disialoganglioside GD2

View more

hTERT-promoter-based tumor-specific expression of MCP-1 effectively sensitizes cervical cancer cells to a low dose of cisplatin

View more

Identification of FGF receptor-binding peptides for cancer gene therapy

View more

Ganciclovir-mediated cell killing and bystander effect is enhanced in cells with two copies of the herpes simplex virus thymidine kinase gene

View more

FAQS